Rosalie E. Ferner - Concepedia

Author

Rosalie E. Ferner

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

D. H. Gutmann, Eamonn Maher, Ferner, R., Marc Tischkowitz, N. J. Ullrich, R E Ferner, R Ferner, R. E. Ferner, R. Ferner, R.E Ferner

169

Publications

11.5K

Citations

H-Index

114

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust King's College London University of Manchester St Mary's Hospital St Thomas' Hospital

About

Rosalie E. Ferner is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, neuropathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	2.2K
2	Health Sciences	5	5	462
3	Social Sciences	4	4	358
4	Public Health	3	3	98
5	Engineering	2	2	80

Rosalie E. Ferner

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation Eric Legius, Ludwine Messiaen, P. Wolkenstein, Genetics in Medicine	2021	687
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Rosalie E. Ferner, David H. Gutmann PubMed Tumor InnervationPeripheral Nerve InjuryPathologyPeripheral NervePeripheral Nerves	2002	609
Second Primary Tumors in Neurofibromatosis 1 Patients Treated for Optic Glioma: Substantial Risks After Radiotherapy Saba Sharif, Rosalie E. Ferner, Jillian M. Birch, Journal of Clinical Oncology	2006	368
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis MJ Fisher, Michael J. Loguidice, David H. Gutmann, Neuro-Oncology	2012	300
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study Rosalie E. Ferner, John F. Golding, Michael A. Smith, Annals of Oncology Positron Emission TomographyNeuro-oncologyLong-term Clinical StudyPeripheral NervesOncologic Imaging	2007	284
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation Scott R. Plotkin, Ludwine Messiaen, Eric Legius, Genetics in Medicine	2022	247
Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 Rosalie E. Ferner Journal of Neurology Neurosurgery & Psychiatry	2000	219
Intellectual impairment in neurofibromatosis 1 Rosalie E. Ferner, Richard AC Hughes, John Weinman Journal of the Neurological Sciences Intellectual ImpairmentNeuropsychologyNeurological DisorderNeurologyNeuroscience	1996	183
Schwannomatosis: a genetic and epidemiological study D. Gareth Evans, Naomi L. Bowers, Simon Tobi, Journal of Neurology Neurosurgery & Psychiatry	2018	158
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1 Victoria Warbey, Rosalie E. Ferner, Joel Dunn, European Journal of Nuclear Medicine and Molecular Imaging Neuro-oncologyTumor InnervationMedicinePathologySpinal Tumor	2009	155

Page 1